Valuation MacroGenics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 16:00:01 2026-06-26 EDT			5-day change	1st Jan Change
4.810 ^USD	+3.22%		+16.46%	+198.76%

06-22	MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment	MT
06-22	MacroGenics Receives Regulatory Milestone Payment From Sanofi Following FDA Accelerated Approval Of TZIELD To Delay Decline In Endogenous Insulin Production In Children Aged Eight To 17 Years With Stage 3 Type 1 Diabetes	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	983.2	412.5	596.7	204	101.8	305.7	-	-
Change	-	-58.04%	44.66%	-65.82%	-50.07%	200.2%	-	-
Enterprise Value (EV)	983.2	412.5	366.9	204	101.8	305.7	305.7	305.7
Change	-	-58.04%	-11.05%	-44.41%	-50.07%	200.2%	0%	0%
P/E	-4.76x	-3.44x	-64.1x	-3.04x	-1.36x	-7.17x	-3.15x	-2.43x
PBR	-	-	-	-	-	-	-	-
PEG	-	0.1x	0.7x	-0x	-0.1x	0.2x	-0x	-0.1x
Capitalization / Revenue	12.7x	2.71x	10.2x	1.36x	0.68x	1.86x	3.24x	2.27x
EV / Revenue	0x	0x	0x	0x	0x	1.86x	3.24x	2.27x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-3.6x	-2.16x	-2.1x
EV / FCF	-0x	-0x	-0x	-0x	-0x	12.4x	-2.11x	-2.24x
FCF Yield	-15.3%	-22%	-13.4%	-35.3%	-81.5%	8.09%	-47.3%	-44.6%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3.37	-1.95	-0.15	-1.07	-1.18	-0.6707	-1.528	-1.98
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	77.45	151.9	58.75	150	149.5	164.4	94.26	135
EBITDA	-191.5	-109.6	-158.6	-	-	-	-	-
EBIT ¹	-202.8	-121.4	-168.2	-110.6	-72.84	-85.03	-141.3	-145.9
Net income ¹	-202.1	-119.8	-9.058	-66.97	-74.62	-18.31	-127	-167.8
Net Debt	-	-	-229.8	-	-	-	-	-
Reference price ²	16.050	6.710	9.620	3.250	1.610	4.810	4.810	4.810
Nbr of stocks (in thousands)	61,258	61,475	62,029	62,763	63,259	63,563	-	-
Announcement Date	2/24/22	3/15/23	3/7/24	3/20/25	3/9/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MACROGENICS, INC.	-7.17x	-	-	-	306M
ARGENX SE	34.2x	8.53x	26.72x	0.05%	55.63B
WUXI APPTEC CO., LTD.	19.78x	6x	13.04x	1.52%	52.25B
BIONTECH SE	-18.16x	4.33x	-7.56x	-.--%	23.07B
INSMED INCORPORATED	-39.15x	12.94x	-37.74x	-.--%	22.41B
WUXI BIOLOGICS (CAYMAN) INC.	21.62x	4.23x	10.97x	-.--%	17.32B
GENMAB A/S	22.36x	4.48x	14.84x	-.--%	15.94B
PHARMAESSENTIA CORPORATION	44.46x	16.86x	51x	-.--%	13.47B
EXELIXIS, INC.	17.25x	5x	11.74x	-.--%	13.77B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-436.4x	29.85x	-3327.81x	-.--%	12.43B
Average	-34.12x	10.25x	-360.53x	0.18%	22.66B
Weighted average by Cap.	-9.79x	8.79x	-172.08x	0.36%